Dallas VA Medical Center
Dallas, Texas, 75216, United States
NCT Number: NCT01405092
Use of on-line blood volume monitoring during continuous renal replacement therapy can improve volume management in acute kidney injury patients requiring renal replacement
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Dallas, Texas, 75216, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
usual care with volume removal during continuous renal replacement therapy
blood volume monitoring device, Critline, Hemametric, USA, will be used in conjunction with continuous renal replacement to determine rate of volume removal
Time frame: 24 hour for each arm
compare the number of hypotensive events during use of crit-line monitor over 24 hour period versus during control 24 hour period
Dallas VA Medical Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06899880
Acute Kidney Injury, Continuous Renal Replacement Therapy
France, Bron
View Trial DetailsNCT04071171
Acute Kidney Injury, Anticoagulation
Innsbruck, Tyrol, Austria
View Trial DetailsNCT03314363
Acute Kidney Injury, Acute Renal Failure
Brussels, Belgium
View Trial DetailsNCT06369064
Acute Kidney Injury, Continuous Renal Replacement Therapy
Nîmes, France
View Trial Details